Brief: Active Biotech Confirms Positive Clinical Safety Profile Of Laquinimod Eye Drops

Active Biotech AB publ

30/01/2023 07:49

Jan 30 (Reuters) - Active Biotech AB publ  ACTI.ST :
    * ACTIVE BIOTECH CONFIRMS POSITIVE CLINICAL SAFETY PROFILE
OF
LAQUINIMOD EYE DROPS
    * NO SERIOUS ADVERSE EVENTS WERE REPORTED.
    * EYE DROP WAS SAFE AND WELL TOLERATED
    * FULL STUDY RESULTS WILL BE REPORTED IN H1 2023

Source text for Eikon:  ID:nMFN6gDmjl 
Further company coverage:  ACTI.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))